From: HADHA promotes ovarian cancer outgrowth via up-regulating CDK1
Features | No. of patients | HADHA expression | P value | |
---|---|---|---|---|
low | high | |||
All patients | 105 | 51 | 54 | Â |
Age (years) | Â | Â | Â | 0.498 |
≤ 51 | 52 | 27 | 25 |  |
>51 | 53 | 24 | 29 | Â |
stage | Â | Â | Â | 0.001 |
1 | 4 | 4 | 0 | Â |
2 | 26 | 21 | 5 | Â |
3 | 54 | 22 | 32 | Â |
4 | 21 | 4 | 17 | Â |
Tumor size (cm) | Â | Â | Â | 0.026 |
≤ 12.5 | 52 | 31 | 21 |  |
> 12.5 | 53 | 20 | 33 |  |
Tumor infiltrate |  |  |  | < 0.001 |
T1 | 4 | 4 | 0 | Â |
T2 | 26 | 21 | 5 | Â |
T3 | 75 | 26 | 49 | Â |
Lymphatic metastasis (N) |  |  |  | < 0.001 |
N0 | 76 | 48 | 28 | Â |
N1 | 29 | 3 | 26 | Â |
Metastasis | Â | Â | Â | 0.003 |
M0 | 84 | 47 | 37 | Â |
M1 | 21 | 4 | 17 | Â |
Recurrence of state | Â | Â | Â | 0.001 |
No | 18 | 15 | 3 | Â |
Yes | 87 | 36 | 51 | Â |